Arthritis Forum
Home.

News.

Personal Stories. Links. Message Board.  
Arthritis Forum  
Add your comments to this topic Start a new topic
Date: 12.09.2013
From: Colin W

Subject: EU Approves Inflectra , copycay Bio drug for RA

European regulators this month approved a biologically similar version of an antibody-based drug for treating rheumatoid arthritis, in a move with global implications.

Essentially, the drug is a biosimilar copycat of Remicade, which is produced by Johnson & Johnson and Merck & Co.

cheaper drugs maybe good news but they never end up as good as the originals

http://www.medicaldaily.com/eu-approves-inflectra-rheumatoid-arthritis-first-biosimilar-antibody-drug-clears-path-greater-256269
reply | back to forum

 

Add your comments to this topic
Subject:
Please type your comment here:

Your name:
email:

4+7=
(This sum is to help prevent automatic spamming through this page - thank-you)


top

Site design: T - Creative Home | News | Personal Stories | Links | Message Board